Posterior Reversible Encephalopathy Occurring During Treatment With Palbociclib

Palbociclib (Ibrance™) has been marketed since 2015 for patients with metastatic hormone-receptor-positive breast cancer. We report here the case of a patient who presented with a posterior reversible encephalopathy syndrome (PRES) during treatment with this new targeted therapy. The 67-year-old wom...

Descripción completa

Detalles Bibliográficos
Autores principales: Belaidi, Lahcene, Baba-Hamed, Nabil, Savinelli, Francesco, Raymond, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382279/
https://www.ncbi.nlm.nih.gov/pubmed/34447643
http://dx.doi.org/10.7759/cureus.16604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382279/
https://www.ncbi.nlm.nih.gov/pubmed/34447643
http://dx.doi.org/10.7759/cureus.16604

Ejemplares similares